NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 197 filers reported holding NEVRO CORP in Q4 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $472,000 | +3.7% | 3,947 | -13.2% | 0.13% | -43.1% |
| Q1 2020 | $455,000 | +175.8% | 4,547 | +224.8% | 0.23% | +625.0% |
| Q4 2019 | $165,000 | +768.4% | 1,400 | +366.7% | 0.03% | +540.0% |
| Q2 2019 | $19,000 | +35.7% | 300 | -15.7% | 0.01% | 0.0% |
| Q4 2018 | $14,000 | -93.9% | 356 | -91.1% | 0.01% | -88.4% |
| Q3 2018 | $230,000 | +2455.6% | 4,000 | +3900.0% | 0.04% | +2050.0% |
| Q1 2018 | $9,000 | -67.9% | 100 | -75.0% | 0.00% | -66.7% |
| Q4 2017 | $28,000 | -74.3% | 400 | -66.7% | 0.01% | -75.0% |
| Q3 2017 | $109,000 | -79.5% | 1,200 | -83.2% | 0.02% | -69.2% |
| Q2 2017 | $532,000 | -43.2% | 7,145 | -28.6% | 0.08% | -27.8% |
| Q1 2017 | $937,000 | +92.4% | 10,000 | +49.2% | 0.11% | +77.0% |
| Q4 2016 | $487,000 | -8.5% | 6,701 | +31.4% | 0.06% | -11.6% |
| Q3 2016 | $532,000 | -18.9% | 5,100 | -42.7% | 0.07% | -24.2% |
| Q2 2016 | $656,000 | – | 8,900 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 1,776,368 | $34,141,793 | 1.08% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $66,424,320 | 1.02% |
| Palo Alto Investors LP | 386,832 | $7,434,911 | 0.70% |
| Rock Springs Capital Management LP | 1,211,600 | $23,286,952 | 0.62% |
| ArrowMark Colorado Holdings LLC | 2,468,110 | $47,437,074 | 0.58% |
| TD Capital Management LLC | 84,648 | $1,626,935 | 0.20% |
| Venator Management LLC | 25,000 | $480,500 | 0.18% |
| DAFNA Capital Management LLC | 28,000 | $538,160 | 0.17% |
| FRED ALGER MANAGEMENT, LLC | 1,053,812 | $20,254,266 | 0.12% |
| Counterpoint Mutual Funds LLC | 6,844 | $131,542 | 0.11% |